Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

BUY
$112.47 - $130.98 $61,183 - $71,253
544 Added 18.07%
3,554 $456,000
Q1 2023

May 15, 2023

BUY
$104.0 - $122.92 $31,616 - $37,367
304 Added 11.23%
3,010 $349,000
Q4 2022

Feb 14, 2023

BUY
$84.98 - $122.67 $229,955 - $331,945
2,706 New
2,706 $306,000
Q2 2022

Aug 15, 2022

BUY
$67.99 - $132.89 $144,614 - $282,657
2,127 Added 302.13%
2,831 $213,000
Q1 2022

May 16, 2022

SELL
$94.08 - $130.2 $111,296 - $154,026
-1,183 Reduced 62.69%
704 $366,000
Q4 2021

Feb 14, 2022

SELL
$129.87 - $162.82 $218,051 - $273,374
-1,679 Reduced 47.08%
1,887 $1.01 Million
Q3 2021

Nov 12, 2021

BUY
$106.71 - $143.18 $21,982 - $29,495
206 Added 6.13%
3,566 $1.95 Million
Q2 2021

Aug 13, 2021

SELL
$80.99 - $107.93 $165,057 - $219,961
-2,038 Reduced 37.75%
3,360 $1.44 Million
Q1 2021

May 14, 2021

SELL
$84.79 - $104.74 $7,970 - $9,845
-94 Reduced 1.71%
5,398 $1.94 Million
Q4 2020

Feb 08, 2021

BUY
$78.0 - $104.5 $5,850 - $7,837
75 Added 1.38%
5,492 $2.03 Million
Q3 2020

Nov 12, 2020

SELL
$95.51 - $112.95 $85,576 - $101,203
-896 Reduced 14.19%
5,417 $2.23 Million
Q2 2020

Jul 17, 2020

SELL
$62.68 - $105.34 $46,571 - $78,267
-743 Reduced 10.53%
6,313 $2.56 Million
Q1 2020

May 12, 2020

SELL
$47.79 - $75.63 $2,293 - $3,630
-48 Reduced 0.68%
7,056 $1.9 Million
Q4 2019

Feb 11, 2020

SELL
$36.62 - $57.29 $6,225 - $9,739
-170 Reduced 2.34%
7,104 $1.55 Million
Q3 2019

Nov 13, 2019

BUY
$35.53 - $43.8 $497 - $613
14 Added 0.19%
7,274 $1.09 Million
Q2 2019

Aug 12, 2019

SELL
$27.84 - $38.92 $1,030 - $1,440
-37 Reduced 0.51%
7,260 $1.09 Million
Q1 2019

May 08, 2019

BUY
$28.07 - $38.18 $3,985 - $5,421
142 Added 1.98%
7,297 $869,000
Q4 2018

Feb 14, 2019

SELL
$26.99 - $37.37 $5,424 - $7,511
-201 Reduced 2.73%
7,155 $857,000
Q3 2018

Nov 14, 2018

SELL
$23.35 - $36.72 $16,461 - $25,887
-705 Reduced 8.75%
7,356 $1.05 Million
Q2 2018

Aug 14, 2018

BUY
$17.54 - $25.22 $141,389 - $203,298
8,061 New
8,061 $765,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $30.9B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Vident Investment Advisory, LLC Portfolio

Follow Vident Investment Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vident Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vident Investment Advisory, LLC with notifications on news.